FBLN1 and neoplasm: However in the development of hepatocellular carcinoma, gastric cancer and prostate cancer, fibulin-1 demonstrated tumor-suppressive activity, suppressing tumor growth, enhancing cell apoptosis and inhibiting tumor angiogenesis [12]–[15].